To view this email as a web page, click here.
 
Cancer drug prices rise despite Trump plan
The manufacturer of 2 cancer drugs hiked the price on the medicines despite President Donald Trump’s new plan to lower drug prices.
Read more
 
FDA backs new biosimilar, plus 2 more
FDA approved the first biosimilar to Neulasta, as well as a new combination treatment for osteoarthritis pain and hypertension, and a new drug to treat chronic lymphocytic leukemia. Here are the top 3 drugs approved in the last week.
Read more
 
Pharmacy chains praise Trump drug pricing plan
Major drug store chains—along with pharmacist organizations—praised President Donald Trump’s new plan to lower prescription drug prices.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.